JR Watkins Menthol Pain Relief Patches Recalled for Manufacturing Deviations
JR Watkins Cooling Pain Relief Patches are being recalled due to manufacturing process deviations identified during production.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II voluntary recall for manufacturing process deviations. No specific safety incident is described. This precautionary recall meets the moderate severity criteria.
Plain-English summary
JR Watkins Cooling Pain Relief Patches (Menthol 7.5%, 5 patches per box, UPC 856294008785) are being recalled due to manufacturing process deviations. The manufacturer, Unexo Life Sciences Private Limited, initiated this voluntary recall in October 2024.
Approximately 10,368 patches were distributed nationwide in the United States.
Consumers with this product should discontinue use. For questions or additional information, contact the manufacturer using information provided on the product packaging.
The recalled product
- Product
- JR WATKINS COOLING PAIN RELIEF PATCHES, Menthol 7.5%, 5 patches per box, Distributed By: J.R. Watkins, LLC, Oakland, CA 94612 UPC 8 56294 00878 5
- Manufacturer
- Unexo Life Sciences Private Limited
- Category
- Drug — Pain Relief Patches
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UPC 8 56294 00878 5
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27